Sustained molecular remission by non-myeloablative stem cell transplantation after autologous hematopoietic stem cell transplantation in a patient with multiple myeloma

References

• Tricot G. Treatment advances in multiple myeloma. Br J Haematol 2004;125:24–30.
   PubMed Web of Science ®Google Scholar
• Bensinger WI. Recent developments in hematopoietic stem cell transplantation for multiple myeloma. Int J Hematol 2003;77:232–238.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Rajk-umar V. Multiple myeloma. N Engl J Med 2004;351:1860–1873.
   PubMed Web of Science ®Google Scholar
• Sirohi B, Powles R Multiple myeloma. Lancet 2004;363:875–887.
   PubMed Web of Science ®Google Scholar
• Attal M, Harousseau JL, Stoppa AM, Sotto jj, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 1996;335:91–97.
   PubMed Web of Science ®Google Scholar
• Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ. High-dose chemotherapy with hematopoietic stem-cell rescue for multi-ple myeloma. N Engl J Med 2003;348:1875–1883.
   Google Scholar
• Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GEG, Cornelissen JJ, Schaafsma MR, van Oers HJ, Wijermans PW et al. Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood 2003;101: 2144–2151.
   Google Scholar
• Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, Tricot G, Munshi N, Fassas A, Singhal S et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999;93:55–65.
   PubMed Web of Science ®Google Scholar
• Attal M, Harousseau JL, Facon T, Gulhot F, Doyen C, Fuzibet JG, Moncondult M, Hulin C, Calliot D, Bouabdallah R et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003;349:2495–2502.
   PubMed Web of Science ®Google Scholar
• Libura J, Hoffmann T, Passweg JR, Gregor M, Fvre G, Tichelli A, Gratwohl A. Graft-versus-myeloma after with-drawal of immunosuppression following allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 1999;24:925–927.
   Google Scholar
• Tricot G, Vesole DH, Jagannath S, Hilton J, Munshi N, Barlogie B. Graft-versus-myeloma effect: proof of principle. Blood 1996;87:1196–1198.
   PubMed Web of Science ®Google Scholar
• Bertz H, Burger JA, Kunzmann R, Mertelsmann R, Finke J. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect. Leukemia 1997;11:281–283.
   Google Scholar
• Bjorkstrand BB, Ljungman P, Svensson H, Hermans J, Alegre A, Apperleym J, Blade J, Carlson K, Cavo M, Ferrant A et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation. Blood 1996;88:4711–4718.
   PubMed Web of Science ®Google Scholar
• Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft versus leukemia effect without myeloablative therapy. Blood 1997;89:4531–4536.
   Google Scholar
• Slavin S, Nagler A, Naperstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel Set al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant diseases. Blood 1998;91:756–763.
   Google Scholar
• McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA et al. Hematopoietic cell transplanta-tion in older patients with hematological malignancies: replacing high-dose cytotoxic therapy with graft versus tumor effects. Blood 2001;97:3390–3400.
   PubMed Web of Science ®Google Scholar
• Bathos A, Barlogie B, Siegel E, Cottler-Fox M, Zangari M, Fassas A, Morris C, Anaissie E, van Rhee F, Tricot G. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative condition-ing. J Chin Oncol 2002;20:1295–1303.
   Google Scholar
• Kroger N, Schwerdtfeger R, Kiehl M, Sayer HG, Renges H, Zabelina T, Fehse B, Tögel F, Wittkowsky G, Kuse R et al. Autologous stem cell transplantation followed by a dose-reduced allograft induced high complete remission rate in multiple myeloma. Blood 2002;100:755–760.
   PubMed Web of Science ®Google Scholar
• Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sndmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T et al. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treat-ment of patients with multiple myeloma. Blood 2003;102:3447–3454.
   PubMed Web of Science ®Google Scholar
• Mitterbauer M, Kalhs P, Keil F, Prinz E, Moser K, Mannhalter C, Mtterbauer G, Brugger S, Gisslinger H, Lechner K et al. Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignan-cies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning. Br J Haematol 2002;118:132–135.
   PubMed Web of Science ®Google Scholar
• Dodero A, Perfetti V, Ciceri F, Corradini P. Clinical and molecular remission following reduced intensity conditioning and allogeneic transplantation in a patient with refractory multiple myeloma. Haematologica 2002;87:ECR41.
   Google Scholar
• Corradini P, Cavo M, Lokhorst H, Martinelli G, Terragna C, Majolino I, Valagussa P, Boccadoro M, Samson D, Baciga-lupo A et al. Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. Blood 2003;102:1927— 1929.
   PubMed Web of Science ®Google Scholar
• Mitus AJ, Stein R, Rappeport JM, Weinstein HJ, Alper CA, Smith BR. Monoclonal and oligoclonal gammopathy after bone marrow transplantation. Blood 1989;75:2764–2768.
   Google Scholar
• Nagashima T, Muroi K, Kawano-Yamamoto C, Komatsu N, Ozawa K. Paraproteinemia after hematopoietic stem cell transplantation. Leuk Lymphoma 2004;45:135–137.
   PubMed Web of Science ®Google Scholar